Exicure, Inc.

Name: Exicure, Inc. standardized financial statements, quarterly
Creator: Listed

XCURNasdaqCIK 1698530HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q2 FY2026

Operating income−$1.1m, Q2 FY2026

Net income−$1.1m, Q2 FY2026

Exicure, Inc., income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$k	0.0	0.0	500	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Research and development	$k	0.0	0.0	0.0	0.0	0.0	0.0	808	935	888	655	312	174
Operating income	$k	(3,317)	(1,498)	(836)	(1,235)	(2,572)	(7,589)	2,923	(2,509)	(2,391)	(2,256)	(1,640)	(1,054)
Interest expense	$k	0.0	0.0	not reported	6.0	12.0	0.0	not reported	not reported	0.0	1.0	not reported	not reported
Income tax	$k	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	(634)	0.0	0.0
Net income	$k	(5,256)	(1,487)	(829)	(600)	(1,091)	(7,181)	3,010	(2,621)	(2,437)	(2,898)	(1,828)	(1,121)
Diluted EPS	$ per share	(3.04)	not reported	(0.48)	(0.35)	(0.57)	not reported	0.49	(0.41)	(0.39)	not reported	(0.29)	(0.18)
Basic EPS	$ per share	(3.04)	not reported	(0.48)	(0.35)	(0.57)	not reported	0.49	(0.41)	(0.39)	not reported	(0.29)	(0.18)

Balance sheet

Cash and equivalents$4.4m, Q3 FY2025

Shareholders' equity$977.0k, Q2 FY2026

Exicure, Inc., balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	0.9	0.8	0.4	0.5	0.3	12.5	10.4	7.9	4.4	not reported	not reported	not reported
Current assets	$m	3.1	2.0	1.5	2.1	2.6	13.7	11.3	8.6	5.4	4.6	3.5	2.3
Total assets	$m	13.0	11.6	10.7	10.7	10.6	15.1	20.7	18.7	15.3	14.0	12.8	11.4
Current liabilities	$m	2.2	2.5	2.7	3.4	3.7	3.1	3.9	4.6	2.8	3.9	4.5	4.2
Total liabilities	$m	8.5	8.5	8.5	9.1	9.1	8.3	9.3	9.9	8.3	10.1	10.7	10.4
Long-term debt	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Current portion of debt	$m	not reported	0.0	not reported	1.0	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Shareholders' equity	$m	4.5	3.0	2.2	1.6	1.5	6.8	11.4	8.9	6.9	3.9	2.1	1.0

Cash flow

Operating cash flow−$887.0k, Q2 FY2026

Capital expenditure−$213.0k, Q4 FY2025

Exicure, Inc., cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	(1,412)	(816)	(450)	(1,166)	(449)	(845)	(1,598)	(2,282)	(3,528)	(1,147)	(1,142)	(887)
Capital expenditure	$k	0.0	0.0	not reported	not reported	0.0	0.0	not reported	not reported	(106)	(213)	not reported	not reported

Diluted shares (weighted)6.37m, Q2 FY2026

Exicure, Inc., shares, quarterly
Line item	Unit	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	k shares	4,963	6,289	8,432	1,730	1,730	1,730	1,899	6,183	6,318	6,322	6,374	6,374

Shares outstanding: 6.55m at Aug 13, 2026, from the cover of the 10-Q filed Aug 14, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.